United States - English - NLM (National Library of Medicine)

mayne pharma inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg in 1 ml - it has been established that ingestion of fluoridated drinking water (1 ppm f) during the period of tooth development results in significant decrease in the incidence of dental caries. sodium fluoride drops 0.5 mg were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to age 3 and older, living in areas where the drinking water fluoride level does not exceed 0.6 ppm f. do not use in areas where drinking water exceeds 0.6 ppm f. do not administer to pediatric patients less than 6 months old.

United States - English - NLM (National Library of Medicine)

lg household and healthcare, inc. - calcium glycerophosphate (unii: xwv9z12c1c) (calcium glycerophosphate - unii:xwv9z12c1c), sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - calcium glycerophosphate .13 g in 100 g - aids in the prevention of : cavity, plaque, bad breath

United States - English - NLM (National Library of Medicine)

sancilio & company inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg in 1 ml - as a supplemental source of fluoride. it has been established that ingestion of fluoridated drinking water (1 ppm f) during the period of tooth development results in significant decrease in the incidence of dental caries.1 sodium fluoride drops were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to age 3 and older, living in areas where the drinking water fluoride level does not exceed 0.6 ppm f. do not use in areas where drinking water exceeds 0.6 ppm f. do not administer to pediatric patients less than 6 months old.

United States - English - NLM (National Library of Medicine)

hto nevada inc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg - for once daily, self-administered, systemic use as a dental caries preventive in pediatric patients.  it has been established that ingestion of fluoridated drinking water ( 1 ppm f ) during the period of tooth development results in a significant decrease in the incidence of dental caries.  kirkman's 1.1 mg sodium fluoride tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients form 6 months to 16 years of age living in areas where the drinking water fluoride content does not exceed 0.6 ppm (f). krikman's 1.1 mg sodium fluoride tablets, are contraindicated when the fluoride content of drinking water is 0.6 ppm (f) or more and should not be administered to pediatric patients under the age of 6 months.  do not administer fluoride (any strength) to pediatric patients under age 6 months. the use of kirkman's 1.1 mg sodium fluoride tablets as a caries preventive in pediatric age groups 6 months to 16 years is supported by evidence from adequate and well-controlled studies

United States - English - NLM (National Library of Medicine)

doctor choi`s korea co., ltd. - hydrated silica 13% calcium glycerophosphate 0.13% sodium fluoride 0.11% tocopheryl acetate 0.1% - purpose anti plaque dental plaque removal tooth decay prevention gum care ■ it keeps them white and makes them strong. ■ keep your mouth clean. ■ refreshes the mouth. ■ prevents tooth decay and removes bad breath. ■ enhance the aesthetic effect. ■ prevention of gingivitis, periodontitis (pyorrhea), prevention of periodontal ■ disease, prevention of gum disease ■ plaque removal (anti-plaque)

United States - English - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 1 mg - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f*) during the period of tooth development results in a significant decrease in the incidence of dental caries. fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to 3 years of age and older living in areas where the drinking water fluoride content does not exceed 0.6 ppm f*. fluoride chewable tablets 1.0 mg are contraindicated when the fluoride content of drinking water is 0.3 ppm f* or more and should not be administered to pediatric patients under the age of 6 years. do not administer fluoride chewable tablets (any strength) to pediatric patients under age 6 months.

United States - English - NLM (National Library of Medicine)

dent-mat holdings, llc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), potassium nitrate (unii: ru45x2jn0z) (nitrate ion - unii:t93e9y2844) - fluoride ion 5 mg in 1 g - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 12 years of age unless recommended by a dentist or physician. 8.1 pregnancy pregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in chi

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. sodium fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm f¯. fluoride 1.0 mg tablets are contraindicated when the fluoride content of drinking water is >0.3 ppm f¯ and should not be administered to pediatric patients under 6 years. fluoride 0.5 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 6 when the fluoride content of drinking water is 0.3 ppm f¯ or more or to pediatric patients under age 3 years. fluoride 0.25 mg tablets are co

United States - English - NLM (National Library of Medicine)

dentsply professional - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 27.3 mg in 1 g - for topical application to aid in the protection against dental caries. hypersensitivity to fluoride. acidulated phosphate fluoride should not be used for patients with porcelain, composite restorations and sealants.

United States - English - NLM (National Library of Medicine)

the great atlantic + pacific tea company - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - sodium fluoride .05 kg in 100 l - antiavity rinse aids in the prevention of dental cavities